Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Paion AG

Start price
Target price
Perf. (%)
€1.23
27.12.21
€2.00
27.12.22
-26.75%
08.09.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€257.65
27.12.21
-
27.12.22
18.26%
28.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Hapag Lloyd AG

Start price
Target price
Perf. (%)
€259.40
27.12.21
-
27.12.22
-25.48%
28.12.22

Good culture
Some uniques
Could be worthwhile Investment >10% per year
Capable Management
buy
Rational AG

Start price
Target price
Perf. (%)
€899.00
27.12.21
-
27.12.22
-38.15%
28.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Very high dividend yield expected
buy
OHB SE

Start price
Target price
Perf. (%)
€36.10
27.12.21
€34.00
27.12.22
-11.08%
28.12.22

Top Rating
Good culture
Very differentiated customer and product portfolio
Small Risks for its business
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
27.12.21
-
27.12.22
-24.02%
08.01.22

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
buy
Biora Therapeutics Inc.

Start price
Target price
Perf. (%)
€50.50
27.12.21
€100.00
27.12.22
-14.36%
10.01.22

Could be very worthwhile Investment >20% year
buy
51 Talk Online Education Group ADR

Start price
Target price
Perf. (%)
€4.08
27.12.21
-
18.01.25
93.63%
27.01.23

Could be worthwhile Investment >10% per year
buy
Neonode Inc.

Start price
Target price
Perf. (%)
€8.40
26.12.21
€6.00
-
28.05.23

Could be worthwhile Investment >10% per year
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€7.34
26.12.21
€10.00
26.12.22
10.35%
25.09.22

Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
buy
IBU tec advanced materials AG

Start price
Target price
Perf. (%)
€48.90
26.12.21
€55.00
26.12.22
-8.79%
08.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
buy
Metaverse Capital Corp.

Start price
Target price
Perf. (%)
€0.003
26.12.21
-
-
30.05.23

Could be worthwhile Investment >10% per year
buy
PVA TePla AG

Start price
Target price
Perf. (%)
€41.85
26.12.21
€48.00
26.12.22
-6.93%
08.01.22

EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Normal challenges to pay loans and raise capital
buy
Secunet Security AG

Start price
Target price
Perf. (%)
€409.50
26.12.21
€450.00
26.12.22
-8.79%
08.01.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Valuable balance sheet
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€28.54
26.12.21
-
26.12.22
-32.45%
14.03.22

Could be worthwhile Investment >10% per year
buy
Navya S.a.

Start price
Target price
Perf. (%)
€2.12
26.12.21
€2.40
26.12.22
-19.01%
30.03.22

Could be worthwhile Investment >10% per year
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.24
26.12.21
-
26.12.22
-7.74%
09.01.22

Risky Investment
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€228.00
25.12.21
€260.00
25.12.22
-15.86%
06.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€224.75
25.12.21
€260.00
25.12.22
-14.41%
06.01.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Daqo New Energy ADR

Start price
Target price
Perf. (%)
€34.80
25.12.21
-
25.12.22
10.34%
26.12.22

Probably not worthwhile Investment
Recon Technology Ltd.

Start price
Target price
Perf. (%)
€1.32
25.12.21
-
25.12.22
-8.14%
26.12.22

Probably not worthwhile Investment
Apollo Medical Holdings, Inc.

Start price
Target price
Perf. (%)
€63.00
25.12.21
-
25.12.22
-56.11%
26.12.22

Probably not worthwhile Investment
China Xiangtai Food Co Ltd.

Start price
Target price
Perf. (%)
€1.21
25.12.21
-
25.12.22
-86.45%
26.12.22

Risky Investment
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year